TAMSULOSIN 0.4mg. IP

An alpha-blocker that treats men with symptoms of an enlarged prostate (benign prostate enlargement. Relaxes smooth muscle in the prostate and bladder neck and enhances bladder emptying. (Lee, 2000) Has a rapid onset of action and is effective in patients with moderate or severe symptoms. (Christopher J Dunn, 2002) A first-line drug treatment for men with moderate to severe LUTS/BPH, especially in those with prostate volumes < 40 cm3. (Jianming Guo, 2021) A valuable agent for the treatment of lower urinary tract symptoms associated with benign prostate hyperplasia. (Jianming Guo, 2021) A useful therapeutic option in the management of patients with moderate to severe lower urinary tract symptoms. (Katherine A Lyseng-Williamson, 2002) A safe, well-tolerated and clinically effective medicine in improving symptoms and urinary flow rate in patients with symptomatic benign prostatic hyperplasia. (P Abrams, 1995) A well-tolerated drug that has no overall negative impact on sexual function as compared to alfuzosin. (K Höfner, 1999) A safe treatment regimen for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia in patients who do not respond to 0.2 mg treatment. (Jung Jun Kim, 2014) A valuable therapeutic option for patients with symptomatic Benign prostatic hyperplasia  and in patients awaiting surgery or in those unable to undergo surgery. (M I Wilde, 1996) Improves urinary symptoms and flow more quickly than finasteride in with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. (P Rigatti, 2003)